To determine the genetically causal role of calmodulin in human MASLD, we conducted summary‐data‐based Mendelian randomization (SMR) analysis to assess the causal associations between genetic variants linked to CALM gene expression levels and the risk of MASLD. Here, CALM3 is linked to metabolic dysfunction-associated steatotic liver disease.